Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
EVINE Live (EVLV) Looks Good: Stock Adds 13.7% in Session
EVINE Live Inc. (EVLV - Free Report) was a big mover last session, as the company saw its shares rise almost 14% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This reverses the recent trend for the company, as the stock is now down nearly 8% in the past one-month time frame.
The company has seen one negative estimate revision in the last 30 days and the Zacks Consensus Estimate moved lower suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s move higher can last.
Currently, EVINE Live carries a Zacks Rank #4 (Sell).
EVINE Live Inc. Price
EVINE Live Inc. Price | EVINE Live Inc. Quote
A better-ranked stock in the same industry is PetMed Express, Inc. (PETS - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is EVLV going up? Or down? Predict to see what others think: Up or Down
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>